Experts will present risk assessment strategies for nitrite detection and quality evaluation to promote safer pharmaceutical formulations with better patient outcomes\u00a0 <\/p>\n
NEW YORK<\/span>, April 29, 2024<\/span> \/PRNewswire\/ — IFF’s Pharma Solutions division will highlight innovative solutions to help pharmaceutical manufacturers seeking science-backed excipients with effective strategies to support their nitrosamine risk mitigation plans at Excipient World 2024, May 13-15<\/span>, Gaylord Palms Resort and Convention Center, Kissimmee, Florida<\/span> at booth 214.<\/p>\n <\/a> Nitrosamine risk assessment and control have become an integral part of pharmaceutical drug product development and quality evaluation. With more than 70 years of expertise in cellulosic excipients, IFF’s pioneering, leading brands \u2500 Avicel\u00ae PH LN, a robust low nitrite microcrystalline cellulose<\/a>\u00a0(MCC) and METHOCEL\u2122 range of water-soluble cellulose ethers<\/a>\u00a0are proven effective in reducing nitrosamines in model formulations.<\/p>\n “As the pharmaceutical landscape evolves, it is important to address and solve any challenges associated with nitrosamine risk,” said Angela Strzelecki<\/span>, president, Pharma Solutions, IFF. “Collaborating with an excipient manufacturer with vital expertise, and robust formulation and analytical capabilities enables drug developers to confidently and efficiently incorporate low nitrite excipients into their formulations.”<\/p>\n Attendees will have the opportunity to meet with IFF experts and discuss areas such as regulatory compliance, quality, consistency, product innovation, and how the Company’s state-of-the-art excipients can help elevate drug formulations, optimize drug delivery, and ultimately contribute to patient well-being.\u00a0<\/p>\n IFF will share nitrosamine analytical insights and the latest scientific advancements during the following informative sessions:<\/p>\n On May 14<\/span>, 11.15 a.m.\u201312.00 p.m. ET, Sun Ballroom, Stage 2, Koudi Zhu, analytical scientist, Pharma Solutions will present on nitrite detection and ensuring safer pharmaceutical formulations, titled “Analytical Method Advances in Measuring Nitrites in Pharmaceutical Excipients”<\/a>. From May 13-15<\/span>, Priscilla Zawislak<\/span>, IFF senior manager, Scientific and Public Affairs, and past chair of IPEC-Americas, will present the importance and role of excipients in oral drug delivery, and regulatory and quality considerations relating to excipients at the Excipients 101 workshop and other educational sessions<\/a>. <\/p>\n Register here<\/a>\u00a0to schedule a meeting at Excipient World 2024.<\/p>\n Welcome to IFF<\/p>\n At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world \u2013 from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partner with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet.\u00a0 Learn more at iff.com<\/a>,\u00a0Twitter<\/a>\u00a0,\u00a0Facebook<\/a>,\u00a0Instagram<\/a>, and\u00a0LinkedIn<\/a>.\u00a0<\/p>\n \u00a92024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with \u2122, SM or \u00ae are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.<\/p>\n
<\/span><\/p>\n<\/div>\n